- Home
- WERN vs EVO Comparison
WERN vs EVO Comparison
Compare WERN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WERN
- EVO
- Stock Information
- Founded
- WERN 1956
- EVO 1993
- Country
- WERN United States
- EVO Germany
- Employees
- WERN N/A
- EVO N/A
- Industry
- WERN Trucking Freight/Courier Services
- EVO Biotechnology: Pharmaceutical Preparations
- Sector
- WERN Industrials
- EVO Health Care
- Exchange
- WERN Nasdaq
- EVO Nasdaq
- Market Cap
- WERN 1.7B
- EVO 1.5B
- IPO Year
- WERN N/A
- EVO 2021
- Fundamental
- Price
- WERN $27.60
- EVO $4.21
- Analyst Decision
- WERN Hold
- EVO Buy
- Analyst Count
- WERN 13
- EVO 2
- Target Price
- WERN $31.31
- EVO $5.90
- AVG Volume (30 Days)
- WERN 944.2K
- EVO 128.3K
- Earning Date
- WERN 07-29-2025
- EVO 08-13-2025
- Dividend Yield
- WERN 2.02%
- EVO N/A
- EPS Growth
- WERN N/A
- EVO N/A
- EPS
- WERN 0.29
- EVO N/A
- Revenue
- WERN $2,973,292,000.00
- EVO $851,944,444.00
- Revenue This Year
- WERN $0.55
- EVO $10.08
- Revenue Next Year
- WERN $6.33
- EVO $10.99
- P/E Ratio
- WERN $97.42
- EVO N/A
- Revenue Growth
- WERN N/A
- EVO 1.50
- 52 Week Low
- WERN $23.02
- EVO $2.84
- 52 Week High
- WERN $42.48
- EVO $5.64
- Technical
- Relative Strength Index (RSI)
- WERN 52.31
- EVO 54.31
- Support Level
- WERN $26.67
- EVO $3.73
- Resistance Level
- WERN $27.87
- EVO $4.29
- Average True Range (ATR)
- WERN 0.86
- EVO 0.11
- MACD
- WERN 0.00
- EVO 0.01
- Stochastic Oscillator
- WERN 50.27
- EVO 67.61
About WERN Werner Enterprises Inc.
Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.